Coloplast A/S (OTCMKTS:CLPBY) Share Price Passes Above Fifty Day Moving Average – Time to Sell?

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $6.09 and traded as high as $6.70. Coloplast A/S shares last traded at $6.68, with a volume of 106,689 shares traded.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on CLPBY shares. The Goldman Sachs Group cut Coloplast A/S from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. Kepler Capital Markets raised Coloplast A/S to a “strong-buy” rating in a report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold”.

Coloplast A/S Stock Performance

The company’s fifty day simple moving average is $6.09 and its two-hundred day simple moving average is $6.86. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.09 and a current ratio of 1.75. The stock has a market capitalization of $15.05 billion, a P/E ratio of 47.71, a PEG ratio of 2.11 and a beta of 0.22.

Coloplast A/S (OTCMKTS:CLPBY) last issued its quarterly earnings data on Tuesday, May 12th. The company reported $0.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. The company had revenue of $1.11 billion during the quarter, compared to analysts’ expectations of $1.11 billion. Coloplast A/S had a return on equity of 33.15% and a net margin of 7.46%. As a group, equities analysts forecast that Coloplast A/S Sponsored ADR will post 0.38 EPS for the current year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.